Strategic Partnerships AUM Biosciences has established strategic collaborations with major players like Handok Inc. and SPRIM Health Group, indicating potential opportunities to leverage these partnerships for sales expansion and market penetration.
Funding Success Having secured a significant amount of funding with a Series A round of $27 million, AUM Biosciences is well-positioned to invest in sales initiatives, product development, and market outreach to drive revenue growth.
Awards Recognition AUM Biosciences' recognition as the 2019 Asia-Pacific Biotech Entrepreneurial Company of the Year highlights its industry leadership and credibility, providing a competitive edge in sales pitches and building customer trust.
Precision Oncology Focus With a strong focus on precision oncology therapeutics and innovative treatment strategies for cancer resistance, AUM Biosciences offers unique solutions in the biotechnology research sector, attracting potential customers seeking advanced oncology treatments.
Investor Confidence Repeated investments from reputable firms like Everlife and backing from SPRIM Global Investments underscore investor confidence in AUM Biosciences, signaling credibility that can be leveraged to attract potential clients and boost sales opportunities.
2
153
$10M$50M
770$100M$1B
62$10M
69$10M$50M
11$10MAUM Biosciences uses 8 technology products and services including Google Analytics, Google Font API, Font Awesome, and more. Explore AUM Biosciences's tech stack below.
| AUM Biosciences Email Formats | Percentage |
| FirstL@aumbiosciences.com | 50% |
| FirstL@aumbiosciences.com | 50% |
Biotechnology ResearchSingapore, Singapore11-50 Employees
AUM Biosciences is focused on advancing a clinical pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance
Company Overview
Media & News
Funding & FinancialsAUM Biosciences has raised a total of $27M of funding over 2 rounds. Their latest funding round was raised on Oct 12, 2021 in the amount of $27M.
Funding & FinancialsAUM Biosciences has raised a total of $27M of funding over 2 rounds. Their latest funding round was raised on Oct 12, 2021 in the amount of $27M.
1-888-653-2347 
support@leadiq.com